EARLY antiplatelet treatment after ischaemic stroke

被引：1
|
作者：
Adams, Harold P., Jr. [1 ]
机构：
[1] Univ Iowa, Div Cerebrovasc Dis, Dept Neurol, Coll Med, Iowa City, IA 52242 USA
来源：
LANCET NEUROLOGY | 2010年 / 9卷 / 02期
关键词：
CONTROLLED-TRIAL; ASPIRIN; ATTACK; DIPYRIDAMOLE; RISK; TIA;
D O I：
10.1016/S1474-4422(09)70364-3
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：131 / 133
页数：3
相关论文
共 50 条
  • [21] Oral antiplatelet therapy for acute ischaemic stroke
    Minhas, Jatinder S.
    Chithiramohan, Tamara
    Wang, Xia
    Barnes, Sam C.
    Clough, Rebecca H.
    Kadicheeni, Meeriam
    Beishon, Lucy C.
    Robinson, Thompson
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (01):
  • [22] Management of ischaemic stroke: statins and antiplatelet agents
    C. Cimminiello
    A. Romano
    Neurological Sciences, 2005, 26 : s24 - s25
  • [23] Antiplatelet treatment for acute secondary prevention of non-cardioembolic minor stroke / transient ischaemic attack: an update for the acute physician
    Krishnan, Kailash
    Law, Zhe Kang
    Minhas, Jatinder S.
    Bath, Philip M.
    Robinson, Thompson G.
    Sprigg, Nikola
    Mavilakandy, Akash
    England, Timothy J.
    Eveson, David
    Mistri, Amit
    Dawson, Jesse
    Appleton, Jason P.
    CLINICAL MEDICINE, 2022, 22 (05) : 449 - 454
  • [24] Management of ischaemic stroke: statins and antiplatelet agents
    Cimminiello, C
    Romano, A
    NEUROLOGICAL SCIENCES, 2005, 26 (Suppl 1) : S24 - S25
  • [25] Dual Antiplatelet Treatment up to 72 Hours after Ischemic Stroke
    Gao, Ying
    Chen, Weiqi
    Pan, Yuesong
    Jing, Jing
    Wang, Chunjuan
    Johnston, S. Claiborne
    Amarenco, Pierre
    Bath, Philip M.
    Jiang, Lingling
    Yang, Yingying
    Wang, Tingting
    Han, Shangrong
    Meng, Xia
    Lin, Jinxi
    Zhao, Xingquan
    Liu, Liping
    Zhao, Jinguo
    Li, Ying
    Zang, Yingzhuo
    Zhang, Shuo
    Yang, Hongqin
    Yang, Jianbo
    Wang, Yuanwei
    Li, Dali
    Wang, Yanxia
    Liu, Dongqi
    Kang, Guangming
    Wang, Yongjun
    Wang, Yilong
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (26): : 2413 - 2424
  • [26] Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic stroke
    W. O. Tobin
    J. A. Kinsella
    G. F. Kavanagh
    J. S. O’Donnell
    R. T. McGrath
    T. Coughlan
    D. R. Collins
    D. O’Neill
    B. Egan
    S. Tierney
    T. M. Feeley
    R. P. Murphy
    D. J. H. McCabe
    Journal of Neurology, 2014, 261 : 1405 - 1412
  • [27] Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack
    Wang, Yongjun
    Johnston, S. Claiborne
    Bath, Philip M.
    Grotta, James C.
    Pan, Yuesong
    Amarenco, Pierre
    Wang, Yilong
    Simon, Tabassome
    Kim, Jong Sung
    Jeng, Jiann-Shing
    Liu, Liping
    Lin, Yi
    Wong, Ka Sing Lawrence
    Wang, David
    Li, Hao
    BMJ-BRITISH MEDICAL JOURNAL, 2019, 364
  • [28] Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality
    Miguel Rivera-Caravaca, Jose
    Marin, Francisco
    Asuncion Esteve-Pastor, Maria
    Valdes, Mariano
    Vicente, Vicente
    Roldan, Vanessa
    Lip, Gregory Y. H.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2018, 72 (03)
  • [29] Risk prediction of very early recurrence, death and progression after acute ischaemic stroke
    Maier, I. L.
    Bauerle, M.
    Kermer, P.
    Helms, H. -J.
    Buettner, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2013, 20 (04) : 599 - +
  • [30] Vitamin K antagonists versus antiplatelet therapy after transient ischaemic attack or minor ischaemic stroke of presumed arterial origin
    De Schryver, Els L. L. M.
    Algra, Ale
    Kappelle, L. Jaap
    van Gijn, Jan
    Koudstaal, Peter J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (09):
12345